{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "molecular mechanisms", "neuroinflammation", "neuroprotective effects", "oxidative damage", "phytochemicals", "protein aggregation"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36143299", "DateRevised": {"Year": "2022", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "15"}], "Language": ["eng"], "ELocationID": ["1515", "10.3390/jpm12091515"], "Journal": {"ISSN": "2075-4426", "JournalIssue": {"Volume": "12", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "15"}}, "Title": "Journal of personalized medicine", "ISOAbbreviation": "J Pers Med"}, "ArticleTitle": "Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation.", "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a neurodegenerative disease characterized by a tangle-shaped accumulation of beta-amyloid peptide fragments and Tau protein in brain neurons. The pathophysiological mechanism involves the presence of A\u03b2-amyloid peptide, Tau protein, oxidative stress, and an exacerbated neuro-inflammatory response. This review aims to offer an updated compendium of the most recent and promising advances in AD treatment through the administration of phytochemicals. The literature survey was carried out by electronic search in the following specialized databases PubMed/Medline, Embase, TRIP database, Google Scholar, Wiley, and Web of Science regarding published works that included molecular mechanisms and signaling pathways targeted by phytochemicals in various experimental models of Alzheimer's disease in vitro and in vivo. The results of the studies showed that the use of phytochemicals against AD has gained relevance due to their antioxidant, anti-neuroinflammatory, anti-amyloid, and anti-hyperphosphorylation properties of Tau protein. Some bioactive compounds from plants have been shown to have the ability to prevent and stop the progression of Alzheimer's."]}, "AuthorList": [{"Identifier": ["0000-0002-7301-8151"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Facultad de Medicina, Universidad del Azuay, Cuenca 14-008, Ecuador."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}, {"Identifier": ["0000-0003-0146-6358"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy."}], "LastName": "Rapposelli", "ForeName": "Simona", "Initials": "S"}, {"Identifier": ["0000-0002-6173-525X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Pharmacy, University of Sassari, Via Vienna 2, 07100 Sassari, Italy."}], "LastName": "Sestito", "ForeName": "Simona", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad Santo Tomas, Talca 3460000, Chile."}, {"Identifier": [], "Affiliation": "Center of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus, Universidad de La Frontera, Temuco 4811230, Chile."}], "LastName": "Herrera-Bravo", "ForeName": "Jes\u00fas", "Initials": "J"}, {"Identifier": ["0000-0001-5682-5800"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad Santo Tomas, Talca 3460000, Chile."}, {"Identifier": [], "Affiliation": "School of Biochemical Engineering, Pontificia Universidad Catolica de Valparaiso, Av. Brasil 2085, Valparaiso 2362803, Chile."}], "LastName": "Arancibia-Diaz", "ForeName": "Alejandra", "Initials": "A"}, {"Identifier": ["0000-0002-5112-6944"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus, Universidad de La Frontera, Temuco 4811230, Chile."}], "LastName": "Salazar", "ForeName": "Luis A", "Initials": "LA"}, {"Identifier": ["0000-0002-1294-6149"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan."}], "LastName": "Yeskaliyeva", "ForeName": "Balakyz", "Initials": "B"}, {"Identifier": ["0000-0001-5225-6217"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Aromatic Plants, University of Health Sciences, Istanbul 34668, Turkey."}], "LastName": "Beyatli", "ForeName": "Ahmet", "Initials": "A"}, {"Identifier": ["0000-0002-7940-1100"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Facultad de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico 04510, Mexico."}], "LastName": "Leyva-G\u00f3mez", "ForeName": "Gerardo", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition and Dietetics, Faculty of Pharmacy, and Centre for Healthy Living, University of Concepci\u00f3n, Concepci\u00f3n 4070386, Chile."}], "LastName": "Gonz\u00e1lez-Contreras", "ForeName": "Carlos", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas 58140, Turkey."}], "LastName": "G\u00fcrer", "ForeName": "Eda S\u00f6nmez", "Initials": "ES"}, {"Identifier": ["0000-0003-3183-7623"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition and Dietetics, Faculty of Pharmacy, and Centre for Healthy Living, University of Concepci\u00f3n, Concepci\u00f3n 4070386, Chile."}], "LastName": "Martorell", "ForeName": "Miquel", "Initials": "M"}, {"Identifier": ["0000-0002-1523-9116"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania."}], "LastName": "Calina", "ForeName": "Daniela", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Pers Med", "NlmUniqueID": "101602269", "ISSNLinking": "2075-4426"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "No authors listed. 2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2020. Online ahead of print .", "ArticleIdList": ["10.1002/alz.12068"]}, {"Citation": "Amor S., Peferoen L.A., Vogel D.Y., Breur M., van der Valk P., Baker D., van Noort J.M. Inflammation in neurodegenerative diseases\u2014An update. Immunology. 2014;142:151\u2013166. doi: 10.1111/imm.12233.", "ArticleIdList": ["10.1111/imm.12233", "PMC4008224", "24329535"]}, {"Citation": "Sharifi-Rad M., Kumar N.V.A., Zucca P., Varoni E.M., Dini L., Panzarini E., Rajkovic J., Fokou P.V.T., Azzini E., Peluso I., et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front. Physiol. 2020;11:21. doi: 10.3389/fphys.2020.00694.", "ArticleIdList": ["10.3389/fphys.2020.00694", "PMC7347016", "32714204"]}, {"Citation": "Siokas V., Aloizou A.M., Tsouris Z., Liampas I., Liakos P., Calina D., Docea A.O., Tsatsakis A., Bogdanos D.P., Hadjigeorgiou G.M., et al. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson\u2019s Disease. J. Clin. Med. 2021;10:381. doi: 10.3390/jcm10030381.", "ArticleIdList": ["10.3390/jcm10030381", "PMC7864159", "33498513"]}, {"Citation": "Jeremic D., Jim\u00e9nez-D\u00edaz L., Navarro-L\u00f3pez J.D. Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer\u2019s disease: A systematic review. Ageing Res. Rev. 2021;72:101496. doi: 10.1016/j.arr.2021.101496.", "ArticleIdList": ["10.1016/j.arr.2021.101496", "34687956"]}, {"Citation": "Epperly T., Dunay M.A., Boice J.L. Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms. Am. Fam. Physician. 2017;95:771\u2013778.", "ArticleIdList": ["28671413"]}, {"Citation": "Sharifi-Rad J., Quispe C., Bouyahya A., El Menyiy N., El Omari N., Shahinozzaman M., Ara Haque Ovey M., Koirala N., Panthi M., Ertani A., et al. Ethnobotany, Phytochemistry, Biological Activities, and Health-Promoting Effects of the Genus Bulbophyllum. Evid. -Based Complementary Altern. Med. 2022;2022:6727609. doi: 10.1155/2022/6727609.", "ArticleIdList": ["10.1155/2022/6727609", "PMC8920616", "35295925"]}, {"Citation": "Vaiserman A., Koliada A., Lushchak O. Neuroinflammation in pathogenesis of Alzheimer\u2019s disease: Phytochemicals as potential therapeutics. Mech. Ageing Dev. 2020;189:111259. doi: 10.1016/j.mad.2020.111259.", "ArticleIdList": ["10.1016/j.mad.2020.111259", "32450086"]}, {"Citation": "Hossain R., Quispe C., Saikat A.S.M., Jain D., Habib A., Janmeda P., Islam M.T., Radha U., Da\u015ftan S.D., Kumar M., et al. Biosynthesis of Secondary Metabolites Based on the Regulation of MicroRNAs. Biomed. Res. Int. 2022;2022:9349897. doi: 10.1155/2022/9349897.", "ArticleIdList": ["10.1155/2022/9349897", "PMC8916866", "35281611"]}, {"Citation": "Hossain R., Sarkar C., Hassan S.M.H., Khan R.A., Arman M., Ray P., Islam M.T., Da\u015ftan S.D., Sharifi-Rad J., Almarhoon Z.M., et al. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation. Chin. J. Integr. Med. 2021;28:249\u2013256. doi: 10.1007/s11655-021-3504-5.", "ArticleIdList": ["10.1007/s11655-021-3504-5", "PMC8672856", "34913151"]}, {"Citation": "Welcome M.O. Blood brain barrier inflammation and potential therapeutic role of phytochemicals. PharmaNutrition. 2020;11:100177. doi: 10.1016/j.phanu.2020.100177.", "ArticleIdList": ["10.1016/j.phanu.2020.100177"]}, {"Citation": "WFO  WFO The World Flora Online.  [(accessed on 23 February 2022)].  Available online:  http://www.worldfloraonline.org/"}, {"Citation": "Chemspider   [(accessed on 23 February 2022)].  Available online:  http://www.chemspider.com/"}, {"Citation": "Arnsten A.F.T., Datta D., Preuss T.M. Studies of aging nonhuman primates illuminate the etiology of early-stage Alzheimer\u2019s-like neuropathology: An evolutionary perspective. Am. J. Primatol. 2021;83:e23254. doi: 10.1002/ajp.23254.", "ArticleIdList": ["10.1002/ajp.23254", "PMC8550995", "33960505"]}, {"Citation": "Ladner C.J., Lee J.M. Pharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited. J. Neuropathol. Exp. Neurol. 1998;57:719\u2013731. doi: 10.1097/00005072-199808000-00001.", "ArticleIdList": ["10.1097/00005072-199808000-00001", "9720487"]}, {"Citation": "Lane R.M., Potkin S.G., Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol. 2006;9:101\u2013124. doi: 10.1017/S1461145705005833.", "ArticleIdList": ["10.1017/S1461145705005833", "16083515"]}, {"Citation": "Zag\u00f3rska A., Jaromin A. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer\u2032s Disease Therapy. Molecules. 2020;25:3337. doi: 10.3390/molecules25153337.", "ArticleIdList": ["10.3390/molecules25153337", "PMC7435667", "32717806"]}, {"Citation": "Cheignon C., Tomas M., Bonnefont-Rousselot D., Faller P., Hureau C., Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol. 2018;14:450\u2013464. doi: 10.1016/j.redox.2017.10.014.", "ArticleIdList": ["10.1016/j.redox.2017.10.014", "PMC5680523", "29080524"]}, {"Citation": "Maccioni R.B., Munoz J.P., Barbeito L. The molecular bases of Alzheimer\u2019s disease and other neurodegenerative disorders. Arch. Med. Res. 2001;32:367\u2013381. doi: 10.1016/S0188-4409(01)00316-2.", "ArticleIdList": ["10.1016/S0188-4409(01)00316-2", "11578751"]}, {"Citation": "Agis-Torres A., Solhuber M., Fernandez M., Sanchez-Montero J.M. Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer\u2019s Disease. Curr. Neuropharmacol. 2014;12:2\u201336. doi: 10.2174/1570159X113116660047.", "ArticleIdList": ["10.2174/1570159X113116660047", "PMC3915347", "24533013"]}, {"Citation": "Tuppo E.E., Arias H.R. The role of inflammation in Alzheimer\u2019s disease. Int. J. Biochem. Cell Biol. 2005;37:289\u2013305. doi: 10.1016/j.biocel.2004.07.009.", "ArticleIdList": ["10.1016/j.biocel.2004.07.009", "15474976"]}, {"Citation": "Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918\u2013934. doi: 10.1016/j.cell.2010.02.016.", "ArticleIdList": ["10.1016/j.cell.2010.02.016", "PMC2873093", "20303880"]}, {"Citation": "Wyss-Coray T. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat. Med. 2006;12:1005\u20131015. doi: 10.1038/nm1484.", "ArticleIdList": ["10.1038/nm1484", "16960575"]}, {"Citation": "Bacci A., Runfola M., Sestito S., Rapposelli S. Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases. Antioxidants. 2021;10:367. doi: 10.3390/antiox10030367.", "ArticleIdList": ["10.3390/antiox10030367", "PMC7997428", "33671015"]}, {"Citation": "Sharifi-Rad J., Quispe C., Herrera-Bravo J., Martorell M., Sharopov F., Tumer T.B., Kurt B., Lankatillake C., Docea A.O., Moreira A.C., et al. A Pharmacological Perspective on Plant-derived Bioactive Molecules for Epilepsy. Neurochem. Res. 2021;46:2205\u20132225. doi: 10.1007/s11064-021-03376-0.", "ArticleIdList": ["10.1007/s11064-021-03376-0", "34120291"]}, {"Citation": "Nesi G., Sestito S., Digiacomo M., Rapposelli S. Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer\u2019s Disease. Curr. Top. Med. Chem. 2017;17:3062\u20133079. doi: 10.2174/1568026617666170607114232.", "ArticleIdList": ["10.2174/1568026617666170607114232", "28595557"]}, {"Citation": "Atri A. The Alzheimer\u2019s Disease Clinical Spectrum: Diagnosis and Management. Med. Clin. N. Am. 2019;103:263\u2013293. doi: 10.1016/j.mcna.2018.10.009.", "ArticleIdList": ["10.1016/j.mcna.2018.10.009", "30704681"]}, {"Citation": "Grundman M., Petersen R.C., Ferris S.H., Thomas R.G., Aisen P.S., Bennett D.A., Foster N.L., Jack C.R., Jr., Galasko D.R., Doody R., et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch. Neurol. 2004;61:59\u201366. doi: 10.1001/archneur.61.1.59.", "ArticleIdList": ["10.1001/archneur.61.1.59", "14732621"]}, {"Citation": "Nussbaum L., Hogea L.M., Calina D., Andreescu N., Gradinaru R., Stefanescu R., Puiu M. Modern treatment approaches in psychoses. pharmacogenetic, neuroimagistic and clinical implications. Farmacia. 2017;65:75\u201381."}, {"Citation": "Zucchella C., Sinforiani E., Tamburin S., Federico A., Mantovani E., Bernini S., Casale R., Bartolo M. The Multidisciplinary Approach to Alzheimer\u2019s Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment. Front. Neurol. 2018;9:1058. doi: 10.3389/fneur.2018.01058.", "ArticleIdList": ["10.3389/fneur.2018.01058", "PMC6300511", "30619031"]}, {"Citation": "Calina D., Buga A.M., Mitroi M., Buha A., Caruntu C., Scheau C., Bouyahya A., El Omari N., El Menyiy N., Docea A.O. The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation-Evidence from In Vivo Studies. J. Clin. Med. 2020;9:2395. doi: 10.3390/jcm9082395.", "ArticleIdList": ["10.3390/jcm9082395", "PMC7464236", "32726998"]}, {"Citation": "Howard R., Liu K.Y. Questions EMERGE as Biogen claims aducanumab turnaround. Nat. Rev. Neurol. 2020;16:63\u201364. doi: 10.1038/s41582-019-0295-9.", "ArticleIdList": ["10.1038/s41582-019-0295-9", "31784690"]}, {"Citation": "Atri A. Current and Future Treatments in Alzheimer\u2019s Disease. Semin. Neurol. 2019;39:227\u2013240. doi: 10.1055/s-0039-1678581.", "ArticleIdList": ["10.1055/s-0039-1678581", "30925615"]}, {"Citation": "Yiannopoulou K.G., Papageorgiou S.G. Current and Future Treatments in Alzheimer Disease: An Update. J. Cent. Nerv. Syst. Dis. 2020;12:1179573520907397. doi: 10.1177/1179573520907397.", "ArticleIdList": ["10.1177/1179573520907397", "PMC7050025", "32165850"]}, {"Citation": "Finn L.A. Current Medications for the Treatment of Alzheimer\u2019s Disease. In: Adejare A., editor. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. Academic Press; Cambridge, MA, USA: 2017. pp. 49\u201358.", "ArticleIdList": ["10.1016/b978-0-12-802810-0.00004-0"]}, {"Citation": "Tricco A.C., Ashoor H.M., Soobiah C., Rios P., Veroniki A.A., Hamid J.S., Ivory J.D., Khan P.A., Yazdi F., Ghassemi M., et al. Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer\u2019s Disease: Systematic Review and Network Metaanalysis. J. Am. Geriatr. Soc. 2018;66:170\u2013178. doi: 10.1111/jgs.15069.", "ArticleIdList": ["10.1111/jgs.15069", "29131306"]}, {"Citation": "Korabecny J., Nepovimova E., Cikankova T., Spilovska K., Vaskova L., Mezeiova E., Kuca K., Hroudova J. Newly Developed Drugs for Alzheimer\u2019s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission. Neuroscience. 2018;370:191\u2013206. doi: 10.1016/j.neuroscience.2017.06.034.", "ArticleIdList": ["10.1016/j.neuroscience.2017.06.034", "28673719"]}, {"Citation": "Wang R., Reddy P.H. Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease. J. Alzheimers Dis. 2017;57:1041\u20131048. doi: 10.3233/JAD-160763.", "ArticleIdList": ["10.3233/JAD-160763", "PMC5791143", "27662322"]}, {"Citation": "Hossain R., Quispe C., Herrera-Bravo J., Beltr\u00e1n J.F., Islam M.T., Shaheen S., Cruz-Martins N., Martorell M., Kumar M., Sharifi-Rad J., et al. Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide. Oxid. Med. Cell. Longev. 2022;2022:3079577. doi: 10.1155/2022/3079577.", "ArticleIdList": ["10.1155/2022/3079577", "PMC8825670", "35154564"]}, {"Citation": "Mallikarjun V., Swift J. Therapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New Tricks. EBioMedicine. 2016;14:24\u201331. doi: 10.1016/j.ebiom.2016.11.020.", "ArticleIdList": ["10.1016/j.ebiom.2016.11.020", "PMC5161440", "27889480"]}, {"Citation": "Bauzon J., Lee G., Cummings J. Repurposed agents in the Alzheimer\u2019s disease drug development pipeline. Alzheimers Res. 2020;12:98. doi: 10.1186/s13195-020-00662-x.", "ArticleIdList": ["10.1186/s13195-020-00662-x", "PMC7433208", "32807237"]}, {"Citation": "Calina D., Sarkar C., Arsene A.L., Salehi B., Docea A.O., Mondal M., Islam M.T., Zali A., Sharifi-Rad J. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development. Immunol. Res. 2020;68:315\u2013324. doi: 10.1007/s12026-020-09154-4.", "ArticleIdList": ["10.1007/s12026-020-09154-4", "PMC7529090", "33006053"]}, {"Citation": "Islam M.T., Nasiruddin M., Khan I.N., Mishra S.K., Kudrat-E-Zahan M., Riaz T.A., Ali E.S., Rahman M.S., Mubarak M.S., Martorell M., et al. A Perspective on Emerging Therapeutic Interventions for COVID-19. Front. Public Health. 2020;8:281. doi: 10.3389/fpubh.2020.00281.", "ArticleIdList": ["10.3389/fpubh.2020.00281", "PMC7362761", "32733837"]}, {"Citation": "Calina D., Hartung T., Docea A.O., Spandidos D.A., Egorov A.M., Shtilman M.I., Carvalho F., Tsatsakis A. COVID-19 vaccines: Ethical framework concerning human challenge studies. Daru. 2020;28:807\u2013812. doi: 10.1007/s40199-020-00371-8.", "ArticleIdList": ["10.1007/s40199-020-00371-8", "PMC7449865", "32851596"]}, {"Citation": "Kostoff R.N., Kanduc D., Porter A.L., Shoenfeld Y., Calina D., Briggs M.B., Spandidos D.A., Tsatsakis A. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol. Rep. 2020;7:1448\u20131458. doi: 10.1016/j.toxrep.2020.10.016.", "ArticleIdList": ["10.1016/j.toxrep.2020.10.016", "PMC7581376", "33110761"]}, {"Citation": "Neagu M., Calina D., Docea A.O., Constantin C., Filippini T., Vinceti M., Drakoulis N., Poulas K., Nikolouzakis T.K., Spandidos D.A., et al. Back to basics in COVID-19: Antigens and antibodies-Completing the puzzle. J. Cell. Mol. Med. 2021;25:4523\u20134533. doi: 10.1111/jcmm.16462.", "ArticleIdList": ["10.1111/jcmm.16462", "PMC8107083", "33734600"]}, {"Citation": "Calina D., Hern\u00e1ndez A.F., Hartung T., Egorov A.M., Izotov B.N., Nikolouzakis T.K., Tsatsakis A., Vlachoyiannopoulos P.G., Docea A.O. Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2. Life. 2021;11:907. doi: 10.3390/life11090907.", "ArticleIdList": ["10.3390/life11090907", "PMC8467884", "34575056"]}, {"Citation": "Cacabelos R. How plausible is an Alzheimer\u2019s disease vaccine? Expert Opin. Drug Discov. 2020;15:1\u20136. doi: 10.1080/17460441.2019.1667329.", "ArticleIdList": ["10.1080/17460441.2019.1667329", "31526140"]}, {"Citation": "Rafii M.S., Sol O., Mobley W.C., Delpretti S., Skotko B.G., Burke A.D., Sabbagh M.N., Yuan S.H., Rissman R.A., Pulsifer M., et al. Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial. JAMA Neurol. 2022;79:565\u2013574. doi: 10.1001/jamaneurol.2022.0983.", "ArticleIdList": ["10.1001/jamaneurol.2022.0983", "PMC9086937", "35532913"]}, {"Citation": "Lacosta A.M., Pascual-Lucas M., Pesini P., Casabona D., P\u00e9rez-Grijalba V., Marcos-Campos I., Sarasa L., Canudas J., Badi H., Monle\u00f3n I., et al. Safety, tolerability and immunogenicity of an active anti-A\u03b2(40) vaccine (ABvac40) in patients with Alzheimer\u2019s disease: A randomised, double-blind, placebo-controlled, phase I trial. Alzheimers Res. 2018;10:12. doi: 10.1186/s13195-018-0340-8.", "ArticleIdList": ["10.1186/s13195-018-0340-8", "PMC5789644", "29378651"]}, {"Citation": "ClinicalTrials.gov  Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer\u2019s Disease (AD) Patients.  [(accessed on 7 September 2022)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT02551809."}, {"Citation": "Wang C.Y., Wang P.N., Chiu M.J., Finstad C.L., Lin F., Lynn S., Tai Y.H., De Fang X., Zhao K., Hung C.H., et al. UB-311, a novel UBITh(\u00ae) amyloid \u03b2 peptide vaccine for mild Alzheimer\u2019s disease. Alzheimers Dement. (N. Y.) 2017;3:262\u2013272. doi: 10.1016/j.trci.2017.03.005.", "ArticleIdList": ["10.1016/j.trci.2017.03.005", "PMC5651432", "29067332"]}, {"Citation": "Kwan P., Konno H., Chan K.Y., Baum L. Rationale for the development of an Alzheimer\u2019s disease vaccine. Hum. Vaccin. Immunother. 2020;16:645\u2013653. doi: 10.1080/21645515.2019.1665453.", "ArticleIdList": ["10.1080/21645515.2019.1665453", "PMC7227628", "31526227"]}, {"Citation": "Novak P., Schmidt R., Kontsekova E., Kovacech B., Smolek T., Katina S., Fialova L., Prcina M., Parrak V., Dal-Bianco P., et al. FUNDAMANT: An interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease. Alzheimers Res. 2018;10:108. doi: 10.1186/s13195-018-0436-1.", "ArticleIdList": ["10.1186/s13195-018-0436-1", "PMC6201586", "30355322"]}, {"Citation": "Koh S.H., Kwon H.S., Choi S.H., Jeong J.H., Na H.R., Lee C.N., Yang Y., Lee A.Y., Lee J.H., Park K.W., et al. Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer\u2019s disease already receiving donepezil: A phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial. Alzheimers Res. 2021;13:66. doi: 10.1186/s13195-021-00803-w.", "ArticleIdList": ["10.1186/s13195-021-00803-w", "PMC7995588", "33771205"]}, {"Citation": "Dow C.T., Greenblatt C.L., Chan E.D., Dow J.F. Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer\u2019s Disease. Microorganisms. 2022;10:424. doi: 10.3390/microorganisms10020424.", "ArticleIdList": ["10.3390/microorganisms10020424", "PMC8880735", "35208878"]}, {"Citation": "Albertini C., Salerno A., de Sena Murteira Pinheiro P., Bolognesi M.L. From combinations to multitarget-directed ligands: A continuum in Alzheimer\u2019s disease polypharmacology. Med. Res. Rev. 2021;41:2606\u20132633. doi: 10.1002/med.21699.", "ArticleIdList": ["10.1002/med.21699", "32557696"]}, {"Citation": "Islam M.T., Quispe C., Martorell M., Docea A.O., Salehi B., Calina D., Reiner \u017d., Sharifi-Rad J. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19. Int. J. Vitam. Nutr. Res. 2022;92:49\u201366. doi: 10.1024/0300-9831/a000694.", "ArticleIdList": ["10.1024/0300-9831/a000694", "33435749"]}, {"Citation": "Tsoukalas D., Zlatian O., Mitroi M., Renieri E., Tsatsakis A., Izotov B.N., Burada F., Sosoi S., Burada E., Buga A.M., et al. A Novel Nutraceutical Formulation Can Improve Motor Activity and Decrease the Stress Level in a Murine Model of Middle-Age Animals. J. Clin. Med. 2021;10:624. doi: 10.3390/jcm10040624.", "ArticleIdList": ["10.3390/jcm10040624", "PMC7915416", "33562115"]}, {"Citation": "Sharifi-Rad M., Lankatillake C., Dias D.A., Docea A.O., Mahomoodally M.F., Lobine D., Chazot P.L., Kurt B., Tumer T.B., Moreira A.C., et al. Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics. J. Clin. Med. 2020;9:19. doi: 10.3390/jcm9041061.", "ArticleIdList": ["10.3390/jcm9041061", "PMC7231062", "32276438"]}, {"Citation": "Aronson J.K. Defining \u2018nutraceuticals\u2019: Neither nutritious nor pharmaceutical. Br. J. Clin. Pharm. 2017;83:8\u201319. doi: 10.1111/bcp.12935.", "ArticleIdList": ["10.1111/bcp.12935", "PMC5338166", "26991455"]}, {"Citation": "Santini A., Cammarata S.M., Capone G., Ianaro A., Tenore G.C., Pani L., Novellino E. Nutraceuticals: Opening the debate for a regulatory framework. Br. J. Clin. Pharm. 2018;84:659\u2013672. doi: 10.1111/bcp.13496.", "ArticleIdList": ["10.1111/bcp.13496", "PMC5867125", "29433155"]}, {"Citation": "Cassidy L., Fernandez F., Johnson J.B., Naiker M., Owoola A.G., Broszczak D.A. Oxidative stress in alzheimer\u2019s disease: A review on emergent natural polyphenolic therapeutics. Complement. Med. 2020;49:102294. doi: 10.1016/j.ctim.2019.102294.", "ArticleIdList": ["10.1016/j.ctim.2019.102294", "32147039"]}, {"Citation": "Ayaz M., Ullah F., Sadiq A., Kim M.O., Ali T. Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer\u2019s Disease and Other Neurological Disorders. Front Pharm. 2019;10:1417. doi: 10.3389/fphar.2019.01417.", "ArticleIdList": ["10.3389/fphar.2019.01417", "PMC6889855", "31849668"]}, {"Citation": "Gustavsson J., Cederberg C., Sonesson U., Otterdijk R., McYbeck A. Global Food Losses and Food Waste: Extent, Causes and Prevention. Food and Agriculture Organization of the United Nations; Rome, Italy: 2011."}, {"Citation": "Sharifi-Rad J., Herrera-Bravo J., Kamiloglu S., Petroni K., Mishra A.P., Monserrat-Mesquida M., Sureda A., Martorell M., Aidarbekovna D.S., Yessimsiitova Z., et al. Recent advances in the therapeutic potential of emodin for human health. Biomed. Pharmacother. 2022;154:113555. doi: 10.1016/j.biopha.2022.113555.", "ArticleIdList": ["10.1016/j.biopha.2022.113555", "36027610"]}, {"Citation": "Taroncher M., Vila-Donat P., Tolosa J., Ruiz M.J., Rodr\u00edguez-Carrasco Y. Biological activity and toxicity of plant nutraceuticals: An overview. Curr. Opin. Food Sci. 2021;42:113\u2013118. doi: 10.1016/j.cofs.2021.05.008.", "ArticleIdList": ["10.1016/j.cofs.2021.05.008"]}, {"Citation": "Gul K., Singh A.K., Jabeen R. Nutraceuticals and Functional Foods: The Foods for the Future World. Crit. Rev. Food Sci. Nutr. 2016;56:2617\u20132627. doi: 10.1080/10408398.2014.903384.", "ArticleIdList": ["10.1080/10408398.2014.903384", "25629711"]}, {"Citation": "Kitic D., Miladinovic B., Randjelovic M., Szopa A., Sharifi-Rad J., Calina D., Seidel V. Anticancer Potential and Other Pharmacological Properties of Prunus armeniaca L.: An Updated Overview. Plants. 2022;11:1885. doi: 10.3390/plants11141885.", "ArticleIdList": ["10.3390/plants11141885", "PMC9325146", "35890519"]}, {"Citation": "Almanza A., Carlesso A., Chintha C., Creedican S., Doultsinos D., Leuzzi B., Luis A., McCarthy N., Montibeller L., More S., et al. Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications. FEBS J. 2019;286:241\u2013278. doi: 10.1111/febs.14608.", "ArticleIdList": ["10.1111/febs.14608", "PMC7379631", "30027602"]}, {"Citation": "Reyes-Fermin L.M., Aparicio-Trejo O.E., Avila-Rojas S.H., Gomez-Sierra T., Martinez-Klimova E., Pedraza-Chaverri J. Natural antioxidants\u2019 effects on endoplasmic reticulum stress-related diseases. Food Chem. Toxicol. 2020;138:111229. doi: 10.1016/j.fct.2020.111229.", "ArticleIdList": ["10.1016/j.fct.2020.111229", "32105807"]}, {"Citation": "Kim G.H., Kim J.E., Rhie S.J., Yoon S. The Role of Oxidative Stress in Neurodegenerative Diseases. Exp. Neurobiol. 2015;24:325\u2013340. doi: 10.5607/en.2015.24.4.325.", "ArticleIdList": ["10.5607/en.2015.24.4.325", "PMC4688332", "26713080"]}, {"Citation": "Chen X., Drew J., Berney W., Lei W. Neuroprotective Natural Products for Alzheimer\u2019s Disease. Cells. 2021;10:1309. doi: 10.3390/cells10061309.", "ArticleIdList": ["10.3390/cells10061309", "PMC8225186", "34070275"]}, {"Citation": "Venkatesan R., Ji E., Kim S.Y. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: A comprehensive review. Biomed. Res. Int. 2015;2015:814068. doi: 10.1155/2015/814068.", "ArticleIdList": ["10.1155/2015/814068", "PMC4446472", "26075266"]}, {"Citation": "Tsoukalas D., Buga A.M., Docea A.O., Sarandi E., Mitrut R., Renieri E., Spandidos D.A., Rogoveanu I., Cercelaru L., Niculescu M., et al. Reversal of brain aging by targeting telomerase: A nutraceutical approach. Int. J. Mol. Med. 2021;48:199. doi: 10.3892/ijmm.2021.5032.", "ArticleIdList": ["10.3892/ijmm.2021.5032", "PMC8448543", "34515324"]}, {"Citation": "Tsoukalas D., Fragkiadaki P., Docea A.O., Alegakis A.K., Sarandi E., Thanasoula M., Spandidos D.A., Tsatsakis A., Razgonova M.P., Calina D. Discovery of potent telomerase activators: Unfolding new therapeutic and anti-aging perspectives. Mol. Med. Rep. 2019;20:3701\u20133708. doi: 10.3892/mmr.2019.10614.", "ArticleIdList": ["10.3892/mmr.2019.10614", "PMC6755196", "31485647"]}, {"Citation": "Piccialli I., Tedeschi V., Caputo L., D\u2019Errico S., Ciccone R., De Feo V., Secondo A., Pannaccione A. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer\u2019s Disease: Focus on Polyphenols and Monoterpenes. Front Pharm. 2022;13:876614. doi: 10.3389/fphar.2022.876614.", "ArticleIdList": ["10.3389/fphar.2022.876614", "PMC9114803", "35600880"]}, {"Citation": "Libro R., Giacoppo S., Soundara Rajan T., Bramanti P., Mazzon E. Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview. Molecules. 2016;21:518. doi: 10.3390/molecules21040518.", "ArticleIdList": ["10.3390/molecules21040518", "PMC6274085", "27110749"]}, {"Citation": "Farooqui A.A. Therapeutic Potentials of Curcumin for Alzheimer Disease. Springer; Berlin/Heidelberg, Germany: 2016."}, {"Citation": "Ali S.K., Hamed A.R., Soltan M.M., Hegazy U.M., Elgorashi E.E., El-Garf I.A., Hussein A.A. In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease. BMC Complement. Altern. Med. 2013;13:121. doi: 10.1186/1472-6882-13-121.", "ArticleIdList": ["10.1186/1472-6882-13-121", "PMC3701527", "23721591"]}, {"Citation": "Chen D. Neuroprotective Effect of Amorphophallus Campanulatus in Stz Induced Alzheimer Rat Model. Afr. J. Tradit. Complement. Altern. Med. 2016;13:47\u201354. doi: 10.21010/ajtcam.v13i4.8.", "ArticleIdList": ["10.21010/ajtcam.v13i4.8", "PMC5413588", "28480351"]}, {"Citation": "Szilagyi G., Nagy Z., Balkay L., Boros I., Emri M., Lehel S., Marian T., Molnar T., Szakall S., Tron L., et al. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: A PET study. J. Neurol. Sci. 2005;229\u2013230:275\u2013284. doi: 10.1016/j.jns.2004.11.053.", "ArticleIdList": ["10.1016/j.jns.2004.11.053", "15760651"]}, {"Citation": "DeKosky S.T., Williamson J.D., Fitzpatrick A.L., Kronmal R.A., Ives D.G., Saxton J.A., Lopez O.L., Burke G., Carlson M.C., Fried L.P., et al. Ginkgo biloba for prevention of dementia: A randomized controlled trial. JAMA. 2008;300:2253\u20132262. doi: 10.1001/jama.2008.683.", "ArticleIdList": ["10.1001/jama.2008.683", "PMC2823569", "19017911"]}, {"Citation": "Lee S.T., Chu K., Sim J.Y., Heo J.H., Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2008;22:222\u2013226. doi: 10.1097/WAD.0b013e31816c92e6.", "ArticleIdList": ["10.1097/WAD.0b013e31816c92e6", "18580589"]}, {"Citation": "Ha S.K., Moon E., Ju M.S., Kim D.H., Ryu J.H., Oh M.S., Kim S.Y. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection. Neuropharmacology. 2012;63:211\u2013223. doi: 10.1016/j.neuropharm.2012.03.016.", "ArticleIdList": ["10.1016/j.neuropharm.2012.03.016", "22465818"]}, {"Citation": "Cioanca O., Hritcu L., Mihasan M., Hancianu M. Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid beta(1-42) rat model of Alzheimer\u2019s disease. Physiol. Behav. 2013;120:193\u2013202. doi: 10.1016/j.physbeh.2013.08.006.", "ArticleIdList": ["10.1016/j.physbeh.2013.08.006", "23958472"]}, {"Citation": "Karakaya S., Koca M., Yilmaz S.V., Yildirim K., Pinar N.M., Demirci B., Brestic M., Sytar O. Molecular Docking Studies of Coumarins Isolated from Extracts and Essential Oils of Zosima absinthifolia Link as Potential Inhibitors for Alzheimer\u2019s Disease. Molecules. 2019;24:722. doi: 10.3390/molecules24040722.", "ArticleIdList": ["10.3390/molecules24040722", "PMC6412260", "30781573"]}, {"Citation": "Arruda M., Viana H., Rainha N., Neng N.R., Rosa J.S., Nogueira J.M., Barreto Mdo C. Anti-acetylcholinesterase and antioxidant activity of essential oils from Hedychium gardnerianum Sheppard ex Ker-Gawl. Molecules. 2012;17:3082\u20133092. doi: 10.3390/molecules17033082.", "ArticleIdList": ["10.3390/molecules17033082", "PMC6268484", "22410418"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., Sadiq A., Khan M.A., Ahmad W., Shah M.R., Imran M., Ahmad S. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: A preliminary anti- Alzheimer\u2019s study. Lipids Health Dis. 2015;14:141. doi: 10.1186/s12944-015-0145-8.", "ArticleIdList": ["10.1186/s12944-015-0145-8", "PMC4632677", "26530857"]}, {"Citation": "Hancianu M., Cioanca O., Mihasan M., Hritcu L. Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats. Phytomedicine. 2013;20:446\u2013452. doi: 10.1016/j.phymed.2012.12.005.", "ArticleIdList": ["10.1016/j.phymed.2012.12.005", "23351960"]}, {"Citation": "Kamal Z., Ullah F., Ayaz M., Sadiq A., Ahmad S., Zeb A., Hussain A., Imran M. Anticholinesterase and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: Potential effectiveness in Alzheimer\u2019s and other neurological disorders. Biol. Res. 2015;48:21. doi: 10.1186/s40659-015-0011-1.", "ArticleIdList": ["10.1186/s40659-015-0011-1", "PMC4393635", "25889712"]}, {"Citation": "Geiser R.J., Chastain S.E., Moss M.A. Regulation of Bace1 Mrna Expression in Alzheimer\u2019S Disease by Green Tea Catechins and Black Tea Theaflavins. Biophys. J. 2017;112:362a. doi: 10.1016/j.bpj.2016.11.1965.", "ArticleIdList": ["10.1016/j.bpj.2016.11.1965"]}, {"Citation": "Chen Z., Mao X., Liu A., Gao X., Chen X., Ye M., Ye J., Liu P., Xu S., Liu J., et al. Osthole, a natural coumarin improves cognitive impairments and BBB dysfunction after transient global brain ischemia in C57 BL/6J mice: Involvement of Nrf2 pathway. Neurochem. Res. 2015;40:186\u2013194. doi: 10.1007/s11064-014-1483-z.", "ArticleIdList": ["10.1007/s11064-014-1483-z", "25424966"]}, {"Citation": "Turner R.S., Thomas R.G., Craft S., van Dyck C.H., Mintzer J., Reynolds B.A., Brewer J.B., Rissman R.A., Raman R., Aisen P.S., et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85:1383\u20131391. doi: 10.1212/WNL.0000000000002035.", "ArticleIdList": ["10.1212/WNL.0000000000002035", "PMC4626244", "26362286"]}, {"Citation": "Moreno L., Puerta E., Suarez-Santiago J.E., Santos-Magalhaes N.S., Ramirez M.J., Irache J.M. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int. J. Pharm. 2017;517:50\u201357. doi: 10.1016/j.ijpharm.2016.11.061.", "ArticleIdList": ["10.1016/j.ijpharm.2016.11.061", "27915007"]}, {"Citation": "Baum L., Lam C.W., Cheung S.K., Kwok T., Lui V., Tsoh J., Lam L., Leung V., Hui E., Ng C., et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 2008;28:110\u2013113. doi: 10.1097/jcp.0b013e318160862c.", "ArticleIdList": ["10.1097/jcp.0b013e318160862c", "18204357"]}, {"Citation": "Kaur N., Dhiman M., Perez-Polo J.R., Mantha A.K. Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Abeta25-35 -induced neurotoxicity in human neuroblastoma cells. J. Neurosci. Res. 2015;93:938\u2013947. doi: 10.1002/jnr.23565.", "ArticleIdList": ["10.1002/jnr.23565", "25677400"]}, {"Citation": "Kong Z.H., Chen X., Hua H.P., Liang L., Liu L.J. The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer\u2019s-Related Pathology via HMGB1 Inhibition. J. Mol. Neurosci. 2017;63:385\u2013395. doi: 10.1007/s12031-017-0989-7.", "ArticleIdList": ["10.1007/s12031-017-0989-7", "29034441"]}, {"Citation": "Videira R., Castanheira P., Graos M., Resende R., Salgueiro L., Faro C., Cavaleiro C. Dose-dependent inhibition of BACE-1 by the monoterpenoid 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer\u2019s disease. J. Nat. Prod. 2014;77:1275\u20131279. doi: 10.1021/np400903w.", "ArticleIdList": ["10.1021/np400903w", "24921156"]}, {"Citation": "Perez-Severiano F., Salvatierra-Sanchez R., Rodriguez-Perez M., Cuevas-Martinez E.Y., Guevara J., Limon D., Maldonado P.D., Medina-Campos O.N., Pedraza-Chaverri J., Santamaria A. S-Allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur. J. Pharm. 2004;489:197\u2013202. doi: 10.1016/j.ejphar.2004.03.001.", "ArticleIdList": ["10.1016/j.ejphar.2004.03.001", "15087243"]}, {"Citation": "Salehi B., Quispe C., Chamkhi I., El Omari N., Balahbib A., Sharifi-Rad J., Bouyahya A., Akram M., Iqbal M., Docea A.O., et al. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. Front. Pharmacol. 2021;11:592654. doi: 10.3389/fphar.2020.592654.", "ArticleIdList": ["10.3389/fphar.2020.592654", "PMC7849684", "33536909"]}, {"Citation": "Sharifi-Rad J., Kamiloglu S., Yeskaliyeva B., Beyatli A., Alfred M.A., Salehi B., Calina D., Docea A.O., Imran M., Kumar N.V.A., et al. Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action. Front. Pharmacol. 2020;11:11. doi: 10.3389/fphar.2020.571459.", "ArticleIdList": ["10.3389/fphar.2020.571459", "PMC7643726", "33192514"]}, {"Citation": "Ali E.S., Akter S., Ramproshad S., Mondal B., Riaz T.A., Islam M.T., Khan I.N., Docea A.O., Calina D., Sharifi-Rad J., et al. Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: An updated overview. Cancer Cell Int. 2022;22:246. doi: 10.1186/s12935-022-02666-z.", "ArticleIdList": ["10.1186/s12935-022-02666-z", "PMC9358858", "35941592"]}, {"Citation": "Youssif K.A., Haggag E.G., Elshamy A.M., Rabeh M.A., Gabr N.M., Seleem A., Salem M.A., Hussein A.S., Krischke M., Mueller M.J., et al. Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts. PLoS ONE. 2019;14:e0223781. doi: 10.1371/journal.pone.0223781.", "ArticleIdList": ["10.1371/journal.pone.0223781", "PMC6834257", "31693694"]}, {"Citation": "Suganthy N., Sri Ramkumar V., Pugazhendhi A., Benelli G., Archunan G. Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: Assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. Environ. Sci. Pollut. Res. Int. 2018;25:10418\u201310433. doi: 10.1007/s11356-017-9789-4.", "ArticleIdList": ["10.1007/s11356-017-9789-4", "28762049"]}, {"Citation": "El-Hawwary S.S., Abd Almaksoud H.M., Saber F.R., Elimam H., Sayed A.M., El Raey M.A., Abdelmohsen U.R. Green-synthesized zinc oxide nanoparticles, anti-Alzheimer potential and the metabolic profiling of Sabal blackburniana grown in Egypt supported by molecular modelling. RSC Adv. 2021;11:18009\u201318025. doi: 10.1039/D1RA01725J.", "ArticleIdList": ["10.1039/D1RA01725J", "PMC9033216", "35480186"]}, {"Citation": "Butterfield D.A., Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 2019;20:148\u2013160. doi: 10.1038/s41583-019-0132-6.", "ArticleIdList": ["10.1038/s41583-019-0132-6", "PMC9382875", "30737462"]}, {"Citation": "Berger J., Dorninger F., Forss-Petter S., Kunze M. Peroxisomes in brain development and function. Biochim. Biophys. Acta. 2016;1863:934\u2013955. doi: 10.1016/j.bbamcr.2015.12.005.", "ArticleIdList": ["10.1016/j.bbamcr.2015.12.005", "PMC4880039", "26686055"]}, {"Citation": "Cheng Y., Bai F. The Association of Tau With Mitochondrial Dysfunction in Alzheimer\u2019s Disease. Front. Neurosci. 2018;12:163. doi: 10.3389/fnins.2018.00163.", "ArticleIdList": ["10.3389/fnins.2018.00163", "PMC5874499", "29623026"]}, {"Citation": "Alshehri M.M., Quispe C., Herrera-Bravo J., Sharifi-Rad J., Tutuncu S., Aydar E.F., Topkaya C., Mertdinc Z., Ozcelik B., Aital M., et al. A Review of Recent Studies on the Antioxidant and Anti-Infectious Properties of Senna Plants. Oxid. Med. Cell. Longev. 2022;2022:6025900. doi: 10.1155/2022/6025900.", "ArticleIdList": ["10.1155/2022/6025900", "PMC8837466", "35154569"]}, {"Citation": "Poprac P., Jomova K., Simunkova M., Kollar V., Rhodes C.J., Valko M. Targeting Free Radicals in Oxidative Stress-Related Human Diseases. Trends Pharm. Sci. 2017;38:592\u2013607. doi: 10.1016/j.tips.2017.04.005.", "ArticleIdList": ["10.1016/j.tips.2017.04.005", "28551354"]}, {"Citation": "Lau F.C., Shukitt-Hale B., Joseph J.A. The beneficial effects of fruit polyphenols on brain aging. Neurobiol. Aging. 2005;26((Suppl. 1)):128\u2013132. doi: 10.1016/j.neurobiolaging.2005.08.007.", "ArticleIdList": ["10.1016/j.neurobiolaging.2005.08.007", "16194581"]}, {"Citation": "Zhang J., Duan D., Song Z.L., Liu T., Hou Y., Fang J. Small molecules regulating reactive oxygen species homeostasis for cancer therapy. Med. Res. Rev. 2021;41:342\u2013394. doi: 10.1002/med.21734.", "ArticleIdList": ["10.1002/med.21734", "32981100"]}, {"Citation": "Chen C.M., Wu C.T., Yang T.H., Chang Y.A., Sheu M.L., Liu S.H. Green Tea Catechin Prevents Hypoxia/Reperfusion-Evoked Oxidative Stress-Regulated Autophagy-Activated Apoptosis and Cell Death in Microglial Cells. J. Agric. Food. Chem. 2016;64:4078\u20134085. doi: 10.1021/acs.jafc.6b01513.", "ArticleIdList": ["10.1021/acs.jafc.6b01513", "27144449"]}, {"Citation": "Sharifi-Rad J., Quispe C., Durazzo A., Lucarini M., Souto E.B., Santini A., Imran M., Moussa A.Y., Mostafa N.M., El-Shazly M., et al. Resveratrol\u2019 biotechnological applications: Enlightening its antimicrobial and antioxidant properties. J. Herb. Med. 2022;32:100550. doi: 10.1016/j.hermed.2022.100550.", "ArticleIdList": ["10.1016/j.hermed.2022.100550"]}, {"Citation": "Behl C., Moosmann B. Oxidative nerve cell death in Alzheimer\u2019s disease and stroke: Antioxidants as neuroprotective compounds. Biol. Chem. 2002;383:521\u2013536. doi: 10.1515/BC.2002.053.", "ArticleIdList": ["10.1515/BC.2002.053", "12033440"]}, {"Citation": "Agostinho P., Cunha R.A., Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Curr. Pharm. Des. 2010;16:2766\u20132778. doi: 10.2174/138161210793176572.", "ArticleIdList": ["10.2174/138161210793176572", "20698820"]}, {"Citation": "Escobar S.J.M., Fong G.M., Winnischofer S.M.B., Simone M., Munoz L., Dennis J.M., Rocha M.E.M., Witting P.K. Anti-proliferative and cytotoxic activities of the flavonoid isoliquiritigenin in the human neuroblastoma cell line SH-SY5Y. Chem. Biol. Interact. 2019;299:77\u201387. doi: 10.1016/j.cbi.2018.11.022.", "ArticleIdList": ["10.1016/j.cbi.2018.11.022", "30502331"]}, {"Citation": "Amin R., Quispe C., Docea A.O., Ydyrys A., Kulbayeva M., Durna Da\u015ftan S., Calina D., Sharifi-Rad J. The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson\u2019s disease and targeted therapies. Neurochem. Int. 2022;158:105376. doi: 10.1016/j.neuint.2022.105376.", "ArticleIdList": ["10.1016/j.neuint.2022.105376", "35667491"]}, {"Citation": "Taheri Y., Quispe C., Herrera-Bravo J., Sharifi-Rad J., Ezzat S.M., Merghany R.M., Shaheen S., Azmi L., Prakash Mishra A., Sener B., et al. Urtica dioica-Derived Phytochemicals for Pharmacological and Therapeutic Applications. Evid. Based Complement. Altern. Med. 2022;2022:4024331. doi: 10.1155/2022/4024331.", "ArticleIdList": ["10.1155/2022/4024331", "PMC8894011", "35251206"]}, {"Citation": "Dhyani P., Quispe C., Sharma E., Bahukhandi A., Sati P., Attri D.C., Szopa A., Sharifi-Rad J., Docea A.O., Mardare I., et al. Anticancer potential of alkaloids: A key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell Int. 2022;22:206. doi: 10.1186/s12935-022-02624-9.", "ArticleIdList": ["10.1186/s12935-022-02624-9", "PMC9161525", "35655306"]}, {"Citation": "Markesbery W.R., Lovell M.A. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 2007;64:954\u2013956. doi: 10.1001/archneur.64.7.954.", "ArticleIdList": ["10.1001/archneur.64.7.954", "17620484"]}, {"Citation": "Ahmad W., Ijaz B., Shabbiri K., Ahmed F., Rehman S. Oxidative toxicity in diabetes and Alzheimer\u2019s disease: Mechanisms behind ROS/ RNS generation. J. Biomed. Sci. 2017;24:76. doi: 10.1186/s12929-017-0379-z.", "ArticleIdList": ["10.1186/s12929-017-0379-z", "PMC5606025", "28927401"]}, {"Citation": "Niedzielska E., Smaga I., Gawlik M., Moniczewski A., Stankowicz P., Pera J., Filip M. Oxidative Stress in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:4094\u20134125. doi: 10.1007/s12035-015-9337-5.", "ArticleIdList": ["10.1007/s12035-015-9337-5", "PMC4937091", "26198567"]}, {"Citation": "Prosdocimi T., De Gioia L., Zampella G., Bertini L. On the generation of OH(.) radical species from H2O2 by Cu(I) amyloid beta peptide model complexes: A DFT investigation. J. Biol. Inorg. Chem. 2016;21:197\u2013212. doi: 10.1007/s00775-015-1322-y.", "ArticleIdList": ["10.1007/s00775-015-1322-y", "26711660"]}, {"Citation": "Zhao Y., Zhao B. Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxid. Med. Cell. Longev. 2013;2013:316523. doi: 10.1155/2013/316523.", "ArticleIdList": ["10.1155/2013/316523", "PMC3745981", "23983897"]}, {"Citation": "Kou J., Kovacs G.G., Hoftberger R., Kulik W., Brodde A., Forss-Petter S., Honigschnabl S., Gleiss A., Brugger B., Wanders R., et al. Peroxisomal alterations in Alzheimer\u2019s disease. Acta Neuropathol. 2011;122:271\u2013283. doi: 10.1007/s00401-011-0836-9.", "ArticleIdList": ["10.1007/s00401-011-0836-9", "PMC3168371", "21594711"]}, {"Citation": "Scheper W., Hoozemans J.J. The unfolded protein response in neurodegenerative diseases: A neuropathological perspective. Acta Neuropathol. 2015;130:315\u2013331. doi: 10.1007/s00401-015-1462-8.", "ArticleIdList": ["10.1007/s00401-015-1462-8", "PMC4541706", "26210990"]}, {"Citation": "Jellinger K.A., Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer\u2019s Disease. J. Alzheimers Dis. 2001;3:31\u201340. doi: 10.3233/JAD-2001-3106.", "ArticleIdList": ["10.3233/JAD-2001-3106", "12214070"]}, {"Citation": "Selkoe D.J., Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 2016;8:595\u2013608. doi: 10.15252/emmm.201606210.", "ArticleIdList": ["10.15252/emmm.201606210", "PMC4888851", "27025652"]}, {"Citation": "Huang B., Liu J., Fu S., Zhang Y., Li Y., He D., Ran X., Yan X., Du J., Meng T., et al. alpha-Cyperone Attenuates H2O2-Induced Oxidative Stress and Apoptosis in SH-SY5Y Cells via Activation of Nrf2. Front. Pharm. 2020;11:281. doi: 10.3389/fphar.2020.00281.", "ArticleIdList": ["10.3389/fphar.2020.00281", "PMC7156596", "32322198"]}, {"Citation": "Othman S., Yabe T. Use of hydrogen peroxide and peroxyl radicals to induce oxidative stress in neuronal cells. Robot. Auton. Syst. 2015;3:40\u201345. doi: 10.7831/ras.3.40.", "ArticleIdList": ["10.7831/ras.3.40"]}, {"Citation": "Wang J., Liu H., Zhang X., Li X., Geng L., Zhang H., Zhang Q. Sulfated Hetero-Polysaccharides Protect SH-SY5Y Cells from H(2)O(2)-Induced Apoptosis by Affecting the PI3K/Akt Signaling Pathway. Mar. Drugs. 2017;15:110. doi: 10.3390/md15040110.", "ArticleIdList": ["10.3390/md15040110", "PMC5408256", "28383489"]}, {"Citation": "Yao D., Wang J., Wang G., Jiang Y., Shang L., Zhao Y., Huang J., Yang S., Wang J., Yu Y. Design, synthesis and biological evaluation of coumarin derivatives as novel acetylcholinesterase inhibitors that attenuate H2O2-induced apoptosis in SH-SY5Y cells. Bioorg. Chem. 2016;68:112\u2013123. doi: 10.1016/j.bioorg.2016.07.013.", "ArticleIdList": ["10.1016/j.bioorg.2016.07.013", "27479541"]}, {"Citation": "Park H.R., Lee H., Park H., Jeon J.W., Cho W.K., Ma J.Y. Neuroprotective effects of Liriope platyphylla extract against hydrogen peroxide-induced cytotoxicity in human neuroblastoma SH-SY5Y cells. BMC Complement. Altern. Med. 2015;15:171. doi: 10.1186/s12906-015-0679-3.", "ArticleIdList": ["10.1186/s12906-015-0679-3", "PMC4459069", "26054856"]}, {"Citation": "Izuta H., Shimazawa M., Tazawa S., Araki Y., Mishima S., Hara H. Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5Y cells. J. Agric. Food Chem. 2008;56:8944\u20138953. doi: 10.1021/jf8014206.", "ArticleIdList": ["10.1021/jf8014206", "18788711"]}, {"Citation": "Juan-Garc\u00eda A., Caprioli G., Sagratini G., Ma\u00f1es J., Juan C. Coffee Silverskin and Spent Coffee Suitable as Neuroprotectors against Cell Death by Beauvericin and \u03b1-Zearalenol: Evaluating Strategies of Treatment. Toxins. 2021;13:132. doi: 10.3390/toxins13020132.", "ArticleIdList": ["10.3390/toxins13020132", "PMC7916764", "33579040"]}, {"Citation": "Gonzalez-Sarrias A., Nunez-Sanchez M.A., Tomas-Barberan F.A., Espin J.C. Neuroprotective Effects of Bioavailable Polyphenol-Derived Metabolites against Oxidative Stress-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells. J. Agric. Food Chem. 2017;65:752\u2013758. doi: 10.1021/acs.jafc.6b04538.", "ArticleIdList": ["10.1021/acs.jafc.6b04538", "28142243"]}, {"Citation": "Han J., Miyamae Y., Shigemori H., Isoda H. Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1. Neuroscience. 2010;169:1039\u20131045. doi: 10.1016/j.neuroscience.2010.05.049.", "ArticleIdList": ["10.1016/j.neuroscience.2010.05.049", "20570715"]}, {"Citation": "Miyamae Y., Han J., Sasaki K., Terakawa M., Isoda H., Shigemori H. 3,4,5-tri-O-caffeoylquinic acid inhibits amyloid beta-mediated cellular toxicity on SH-SY5Y cells through the upregulation of PGAM1 and G3PDH. Cytotechnology. 2011;63:191\u2013200. doi: 10.1007/s10616-011-9341-1.", "ArticleIdList": ["10.1007/s10616-011-9341-1", "PMC3080471", "21424281"]}, {"Citation": "Uberti D., Piccioni L., Colzi A., Bravi D., Canonico P.L., Memo M. Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2) Eur. J. Pharm. 2002;434:17\u201320. doi: 10.1016/S0014-2999(01)01537-0.", "ArticleIdList": ["10.1016/S0014-2999(01)01537-0", "11755160"]}, {"Citation": "Shipley M.M., Mangold C.A., Szpara M.L. Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line. J. Vis. Exp. 2016;108:53193. doi: 10.3791/53193.", "ArticleIdList": ["10.3791/53193", "PMC4828168", "26967710"]}, {"Citation": "Kovalevich J., Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol. Biol. 2013;1078:9\u201321. doi: 10.1007/978-1-62703-640-5_2.", "ArticleIdList": ["10.1007/978-1-62703-640-5_2", "PMC5127451", "23975817"]}, {"Citation": "Angeloni S., Freschi M., Marrazzo P., Hrelia S., Beghelli D., Juan-Garcia A., Juan C., Caprioli G., Sagratini G., Angeloni C. Antioxidant and Anti-Inflammatory Profiles of Spent Coffee Ground Extracts for the Treatment of Neurodegeneration. Oxid. Med. Cell. Longev. 2021;2021:6620913. doi: 10.1155/2021/6620913.", "ArticleIdList": ["10.1155/2021/6620913", "PMC8159652", "34104310"]}, {"Citation": "Amato A., Terzo S., Mule F. Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer\u2019s Disease. Antioxidants. 2019;8:608. doi: 10.3390/antiox8120608.", "ArticleIdList": ["10.3390/antiox8120608", "PMC6943487", "31801234"]}, {"Citation": "Li Y., Shi W., Li Y., Zhou Y., Hu X., Song C., Ma H., Wang C., Li Y. Neuroprotective effects of chlorogenic acid against apoptosis of PC12 cells induced by methylmercury. Environ. Toxicol. Pharm. 2008;26:13\u201321. doi: 10.1016/j.etap.2007.12.008.", "ArticleIdList": ["10.1016/j.etap.2007.12.008", "21783882"]}, {"Citation": "Kwon S.H., Lee H.K., Kim J.A., Hong S.I., Kim H.C., Jo T.H., Park Y.I., Lee C.K., Kim Y.B., Lee S.Y., et al. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharm. 2010;649:210\u2013217. doi: 10.1016/j.ejphar.2010.09.001.", "ArticleIdList": ["10.1016/j.ejphar.2010.09.001", "20854806"]}, {"Citation": "Fukuyama K., Kakio S., Nakazawa Y., Kobata K., Funakoshi-Tago M., Suzuki T., Tamura H. Roasted Coffee Reduces beta-Amyloid Production by Increasing Proteasomal beta-Secretase Degradation in Human Neuroblastoma SH-SY5Y Cells. Mol. Nutr. Food Res. 2018;62:e1800238. doi: 10.1002/mnfr.201800238.", "ArticleIdList": ["10.1002/mnfr.201800238", "30144352"]}, {"Citation": "Naveed M., Hejazi V., Abbas M., Kamboh A.A., Khan G.J., Shumzaid M., Ahmad F., Babazadeh D., FangFang X., Modarresi-Ghazani F., et al. Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomed. Pharm. 2018;97:67\u201374. doi: 10.1016/j.biopha.2017.10.064.", "ArticleIdList": ["10.1016/j.biopha.2017.10.064", "29080460"]}, {"Citation": "Oboh G., Agunloye O.M., Akinyemi A.J., Ademiluyi A.O., Adefegha S.A. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer\u2019s disease and some pro-oxidant induced oxidative stress in rats\u2019 brain-in vitro. Neurochem. Res. 2013;38:413\u2013419. doi: 10.1007/s11064-012-0935-6.", "ArticleIdList": ["10.1007/s11064-012-0935-6", "23184188"]}, {"Citation": "Vauzour D., Corona G., Spencer J.P. Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Arch. Biochem. Biophys. 2010;501:106\u2013111. doi: 10.1016/j.abb.2010.03.016.", "ArticleIdList": ["10.1016/j.abb.2010.03.016", "20361927"]}, {"Citation": "Gao L., Li X., Meng S., Ma T., Wan L., Xu S. Chlorogenic Acid Alleviates Abeta25-35-Induced Autophagy and Cognitive Impairment via the mTOR/TFEB Signaling Pathway. Drug Desigh Dev. 2020;14:1705\u20131716. doi: 10.2147/DDDT.S235969.", "ArticleIdList": ["10.2147/DDDT.S235969", "PMC7221680", "32440096"]}, {"Citation": "Kim S.S., Park R.Y., Jeon H.J., Kwon Y.S., Chun W. Neuroprotective effects of 3,5-dicaffeoylquinic acid on hydrogen peroxide-induced cell death in SH-SY5Y cells. Phytother. Res. 2005;19:243\u2013245. doi: 10.1002/ptr.1652.", "ArticleIdList": ["10.1002/ptr.1652", "15934031"]}, {"Citation": "Ceulemans A.G., Zgavc T., Kooijman R., Hachimi-Idrissi S., Sarre S., Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: Modulatory effects of hypothermia. J. Neuroinflammation. 2010;7:74. doi: 10.1186/1742-2094-7-74.", "ArticleIdList": ["10.1186/1742-2094-7-74", "PMC2988764", "21040547"]}, {"Citation": "Taylor D.L., Jones F., Kubota E.S., Pocock J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J. Neurosci. 2005;25:2952\u20132964. doi: 10.1523/JNEUROSCI.4456-04.2005.", "ArticleIdList": ["10.1523/JNEUROSCI.4456-04.2005", "PMC6725132", "15772355"]}, {"Citation": "MacEwan D.J. TNF receptor subtype signalling: Differences and cellular consequences. Cell Signal. 2002;14:477\u2013492. doi: 10.1016/S0898-6568(01)00262-5.", "ArticleIdList": ["10.1016/S0898-6568(01)00262-5", "11897488"]}, {"Citation": "Salehi B., Sestito S., Rapposelli S., Peron G., Calina D., Sharifi-Rad M., Sharopov F., Martins N., Sharifi-Rad J. Epibatidine: A Promising Natural Alkaloid in Health. Biomolecules. 2019;9:6. doi: 10.3390/biom9010006.", "ArticleIdList": ["10.3390/biom9010006", "PMC6359223", "30583611"]}, {"Citation": "Gonzalez-Gallego J., Garcia-Mediavilla M.V., Sanchez-Campos S., Tunon M.J. Fruit polyphenols, immunity and inflammation. Br. J. Nutr. 2010;104((Suppl. 3)):S15\u2013S27. doi: 10.1017/S0007114510003910.", "ArticleIdList": ["10.1017/S0007114510003910", "20955647"]}, {"Citation": "Spencer J.P., Vafeiadou K., Williams R.J., Vauzour D. Neuroinflammation: Modulation by flavonoids and mechanisms of action. Mol. Asp. Med. 2012;33:83\u201397. doi: 10.1016/j.mam.2011.10.016.", "ArticleIdList": ["10.1016/j.mam.2011.10.016", "22107709"]}, {"Citation": "Pennisi M., Crupi R., Di Paola R., Ontario M.L., Bella R., Calabrese E.J., Crea R., Cuzzocrea S., Calabrese V. Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease. J. Neurosci. Res. 2017;95:1360\u20131372. doi: 10.1002/jnr.23986.", "ArticleIdList": ["10.1002/jnr.23986", "27862176"]}, {"Citation": "Cheng K.C., Chiang H.C. XBP1 and PERK Have Distinct Roles in Abeta-Induced Pathology. Mol. Neurobiol. 2018;55:7523\u20137532. doi: 10.1007/s12035-018-0942-y.", "ArticleIdList": ["10.1007/s12035-018-0942-y", "29427089"]}, {"Citation": "Rathnayake A.U., Abuine R., Palanisamy S., Lee J.K., Byun H.-G. Characterization and purification of \u03b2\u2212secretase inhibitory peptides fraction from sea cucumber (Holothuria spinifera) enzymatic hydrolysates. Process Biochem. 2021;111:86\u201396. doi: 10.1016/j.procbio.2021.10.007.", "ArticleIdList": ["10.1016/j.procbio.2021.10.007"]}, {"Citation": "Ma E.-H., Rathnayake A.U., Lee J.K., Lee S.-M., Byun H.-G. Characterization of \u03b2-secretase inhibitory extracts from sea cucumber (Stichopus japonicus) hydrolysis with their cellular level mechanism in SH-SY5Y cells. Eur. Food Res. Technol. 2021;247:2039\u20132052. doi: 10.1007/s00217-021-03770-6.", "ArticleIdList": ["10.1007/s00217-021-03770-6"]}, {"Citation": "Chougle S., Kumar D., Khan A., Zehra S., Al\u0130 A. Treatment of Alzheimer\u2019s disease by natural products. J. Exp. Clin. Med. 2021;38:634\u2013644. doi: 10.52142/omujecm.38.4.42.", "ArticleIdList": ["10.52142/omujecm.38.4.42"]}, {"Citation": "Wang L., Yin Y.L., Liu X.Z., Shen P., Zheng Y.G., Lan X.R., Lu C.B., Wang J.Z. Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl. Neurodegener. 2020;9:10. doi: 10.1186/s40035-020-00189-z.", "ArticleIdList": ["10.1186/s40035-020-00189-z", "PMC7119290", "32266063"]}, {"Citation": "Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., Shytle R.D., Tan J. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 2008;1214:177\u2013187. doi: 10.1016/j.brainres.2008.02.107.", "ArticleIdList": ["10.1016/j.brainres.2008.02.107", "18457818"]}, {"Citation": "Williams R.J., Spencer J.P. Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic. Biol. Med. 2012;52:35\u201345. doi: 10.1016/j.freeradbiomed.2011.09.010.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.09.010", "21982844"]}, {"Citation": "Arya A., Chahal R., Rao R., Rahman M.H., Kaushik D., Akhtar M.F., Saleem A., Khalifa S.M.A., El-Seedi H.R., Kamel M., et al. Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer\u2019s Disease Therapy. Biomolecules. 2021;11:350. doi: 10.3390/biom11030350.", "ArticleIdList": ["10.3390/biom11030350", "PMC7996600", "33669097"]}, {"Citation": "Ali T., Kim T., Rehman S.U., Khan M.S., Amin F.U., Khan M., Ikram M., Kim M.O. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer\u2019s Disease. Mol. Neurobiol. 2018;55:6076\u20136093. doi: 10.1007/s12035-017-0798-6.", "ArticleIdList": ["10.1007/s12035-017-0798-6", "29170981"]}, {"Citation": "Shih P.H., Chan Y.C., Liao J.W., Wang M.F., Yen G.C. Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer\u2019s disease. J. Nutr. Biochem. 2010;21:598\u2013605. doi: 10.1016/j.jnutbio.2009.03.008.", "ArticleIdList": ["10.1016/j.jnutbio.2009.03.008", "19443193"]}, {"Citation": "Yamakawa M.Y., Uchino K., Watanabe Y., Adachi T., Nakanishi M., Ichino H., Hongo K., Mizobata T., Kobayashi S., Nakashima K., et al. Anthocyanin suppresses the toxicity of Abeta deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer\u2019s disease. Nutr. Neurosci. 2016;19:32\u201342. doi: 10.1179/1476830515Y.0000000042.", "ArticleIdList": ["10.1179/1476830515Y.0000000042", "26304685"]}, {"Citation": "Wu P.Q., Li B., Yu Y.F., Su P.J., Liu X., Zhang Z.P., Zhi D.J., Qi F.M., Fei D.Q., Zhang Z.X. Isolation, Characterization, and Possible Anti-Alzheimer\u2019s Disease Activities of Bisabolane-Type Sesquiterpenoid Derivatives and Phenolics from the Rhizomes of Curcuma longa. Chem. Biodivers. 2020;17:e2000067. doi: 10.1002/cbdv.202000067.", "ArticleIdList": ["10.1002/cbdv.202000067", "32154990"]}, {"Citation": "Farkhondeh T., Forouzanfar F., Roshanravan B., Samarghandian S. Curcumin effect on non-amyloidogenic pathway for preventing Alzheime\u2019 s disease. Biointerface Res. Appl. Chem. 2019;9:4085\u20134089."}, {"Citation": "Den Haan J., Morrema T.H.J., Rozemuller A.J., Bouwman F.H., Hoozemans J.J.M. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer\u2019s disease brains: Implications for in-vivo diagnostics. Acta Neuropathol. Commun. 2018;6:75. doi: 10.1186/s40478-018-0577-2.", "ArticleIdList": ["10.1186/s40478-018-0577-2", "PMC6083624", "30092839"]}, {"Citation": "Giacomeli R., Izoton J.C., Dos Santos R.B., Boeira S.P., Jesse C.R., Haas S.E. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer\u2019s disease induced by beta-amyloid 1-42 peptide in aged female mice. Brain Res. 2019;1721:146325. doi: 10.1016/j.brainres.2019.146325.", "ArticleIdList": ["10.1016/j.brainres.2019.146325", "31325424"]}, {"Citation": "Capiralla H., Vingtdeux V., Zhao H., Sankowski R., Al-Abed Y., Davies P., Marambaud P. Resveratrol mitigates lipopolysaccharide- and Abeta-mediated microglial inflammation by inhibiting the TLR4/NF-kappaB/STAT signaling cascade. J. Neurochem. 2012;120:461\u2013472. doi: 10.1111/j.1471-4159.2011.07594.x.", "ArticleIdList": ["10.1111/j.1471-4159.2011.07594.x", "PMC3253186", "22118570"]}, {"Citation": "Vingtdeux V., Giliberto L., Zhao H., Chandakkar P., Wu Q., Simon J.E., Janle E.M., Lobo J., Ferruzzi M.G., Davies P., et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 2010;285:9100\u20139113. doi: 10.1074/jbc.M109.060061.", "ArticleIdList": ["10.1074/jbc.M109.060061", "PMC2838330", "20080969"]}, {"Citation": "Seo E.J., Fischer N., Efferth T. Phytochemicals as inhibitors of NF-kappaB for treatment of Alzheimer\u2019s disease. Pharm. Res. 2018;129:262\u2013273. doi: 10.1016/j.phrs.2017.11.030.", "ArticleIdList": ["10.1016/j.phrs.2017.11.030", "29179999"]}, {"Citation": "Gomes B.A.Q., Silva J.P.B., Romeiro C.F.R., Dos Santos S.M., Rodrigues C.A., Goncalves P.R., Sakai J.T., Mendes P.F.S., Varela E.L.P., Monteiro M.C. Neuroprotective Mechanisms of Resveratrol in Alzheimer\u2019s Disease: Role of SIRT1. Oxid. Med. Cell. Longev. 2018;2018:8152373. doi: 10.1155/2018/8152373.", "ArticleIdList": ["10.1155/2018/8152373", "PMC6232815", "30510627"]}, {"Citation": "Cai Z., Wang C., Yang W. Role of berberine in Alzheimer\u2019s disease. Neuropsychiatr. Dis. Treat. 2016;12:2509\u20132520. doi: 10.2147/NDT.S114846.", "ArticleIdList": ["10.2147/NDT.S114846", "PMC5055107", "27757035"]}, {"Citation": "Ji H.F., Shen L. Berberine: A potential multipotent natural product to combat Alzheimer\u2019s disease. Molecules. 2011;16:6732\u20136740. doi: 10.3390/molecules16086732.", "ArticleIdList": ["10.3390/molecules16086732", "PMC6264702", "21829148"]}, {"Citation": "Yuan N.N., Cai C.Z., Wu M.Y., Su H.X., Li M., Lu J.H. Neuroprotective effects of berberine in animal models of Alzheimer\u2019s disease: A systematic review of pre-clinical studies. BMC Complement. Altern. Med. 2019;19:109. doi: 10.1186/s12906-019-2510-z.", "ArticleIdList": ["10.1186/s12906-019-2510-z", "PMC6533761", "31122236"]}, {"Citation": "Vecchio I., Sorrentino L., Paoletti A., Marra R., Arbitrio M. The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer\u2019s Disease. J. Cent. Nerv. Syst. Dis. 2021;13:11795735211029113. doi: 10.1177/11795735211029113.", "ArticleIdList": ["10.1177/11795735211029113", "PMC8267037", "34285627"]}, {"Citation": "Santos G.S., Sinoti S.B.P., de Almeida F.T.C., Silveira D., Simeoni L.A., Gomes-Copeland K.K.P. Use of galantamine in the treatment of Alzheimer\u2019s disease and strategies to optimize its biosynthesis using the in vitro culture technique. Plant Cell Tissue Organ Cult. (PCTOC) 2020;143:13\u201329. doi: 10.1007/s11240-020-01911-5.", "ArticleIdList": ["10.1007/s11240-020-01911-5"]}, {"Citation": "Saito T., Hisahara S., Iwahara N., Emoto M.C., Yokokawa K., Suzuki H., Manabe T., Matsumura A., Suzuki S., Matsushita T., et al. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer\u2019s disease. Free Radic. Biol. Med. 2019;145:20\u201332. doi: 10.1016/j.freeradbiomed.2019.09.014.", "ArticleIdList": ["10.1016/j.freeradbiomed.2019.09.014", "31536772"]}, {"Citation": "Castillo W.O., Palomino N.V., Takahashi C.S., Giuliatti S. Genistein and Galantamine Combinations Decrease beta-Amyloid Peptide (1-42)-Induced Genotoxicity and Cell Death in SH-SY5Y Cell Line: An In Vitro and In Silico Approach for Mimic of Alzheimer\u2019s Disease. Neurotox. Res. 2020;38:691\u2013706. doi: 10.1007/s12640-020-00243-8.", "ArticleIdList": ["10.1007/s12640-020-00243-8", "32613603"]}, {"Citation": "Gomaa A.A., Makboul R.M., El-Mokhtar M.A., Abdel-Rahman E.A., Ahmed I.A., Nicola M.A. Terpenoid-rich Elettaria cardamomum extract prevents Alzheimer-like alterations induced in diabetic rats via inhibition of GSK3beta activity, oxidative stress and pro-inflammatory cytokines. Cytokine. 2019;113:405\u2013416. doi: 10.1016/j.cyto.2018.10.017.", "ArticleIdList": ["10.1016/j.cyto.2018.10.017", "30539783"]}, {"Citation": "Awasthi M., Upadhyay A.K., Singh S., Pandey V.P., Dwivedi U.N. Terpenoids as promising therapeutic molecules against Alzheimer\u2019s disease: Amyloid beta- and acetylcholinesterase-directed pharmacokinetic and molecular docking analyses. Mol. Simul. 2017;44:1\u201311. doi: 10.1080/08927022.2017.1334880.", "ArticleIdList": ["10.1080/08927022.2017.1334880"]}, {"Citation": "Koirala P., Seong S.H., Jung H.A., Choi J.S. Comparative molecular docking studies of lupeol and lupenone isolated from Pueraria lobata that inhibits BACE1: Probable remedies for Alzheimer\u2019s disease. Asian Pac. J. Trop. Med. 2017;10:1117\u20131122. doi: 10.1016/j.apjtm.2017.10.018.", "ArticleIdList": ["10.1016/j.apjtm.2017.10.018", "29268966"]}, {"Citation": "Jiang Y., Gao H., Turdu G. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer\u2019s disease: A review. Bioorg. Chem. 2017;75:50\u201361. doi: 10.1016/j.bioorg.2017.09.004.", "ArticleIdList": ["10.1016/j.bioorg.2017.09.004", "28915465"]}, {"Citation": "Wojtunik-Kulesza K.A., Targowska-Duda K., Klimek K., Ginalska G., J\u00f3\u017awiak K., Waksmundzka-Hajnos M., Cie\u015bla \u0141. Volatile terpenoids as potential drug leads in Alzheimer\u2019s disease. Open Chem. 2017;15:332\u2013343. doi: 10.1515/chem-2017-0040.", "ArticleIdList": ["10.1515/chem-2017-0040"]}, {"Citation": "Suganthy N., Pandima Devi K. Protective effect of catechin rich extract of Rhizophora mucronata against \u03b2-amyloid-induced toxicity in PC12 cells. J. Appl. Biomed. 2016;14:137\u2013146. doi: 10.1016/j.jab.2015.10.003.", "ArticleIdList": ["10.1016/j.jab.2015.10.003"]}, {"Citation": "Okello E.J., Mather J. Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer\u2019s Disease. Nutrients. 2020;12:1090. doi: 10.3390/nu12041090.", "ArticleIdList": ["10.3390/nu12041090", "PMC7230519", "32326457"]}, {"Citation": "Cruz-Gonzalez T., Cortez-Torres E., Perez-Severiano F., Espinosa B., Guevara J., Perez-Benitez A., Melendez F.J., Diaz A., Ramirez R.E. Antioxidative stress effect of epicatechin and catechin induced by Abeta25-35 in rats and use of the electrostatic potential and the Fukui function as a tool to elucidate specific sites of interaction. Neuropeptides. 2016;59:89\u201395. doi: 10.1016/j.npep.2016.04.001.", "ArticleIdList": ["10.1016/j.npep.2016.04.001", "27118677"]}, {"Citation": "Ide K., Matsuoka N., Yamada H., Furushima D., Kawakami K. Effects of Tea Catechins on Alzheimer\u2019s Disease: Recent Updates and Perspectives. Molecules. 2018;23:2357. doi: 10.3390/molecules23092357.", "ArticleIdList": ["10.3390/molecules23092357", "PMC6225145", "30223480"]}, {"Citation": "Anggreani E., Cy L. Neuroprotective Effect of Chlorogenic Acids against Alzheime\u2019s Disease. Int. J. Food Sci. 2017;649:330\u2013337."}, {"Citation": "Agunloye O.M., Oboh G. Caffeic acid and chlorogenic acid: Evaluation of antioxidant effect and inhibition of key enzymes linked with hypertension. J. Food Biochem. 2018;42:e12541. doi: 10.1111/jfbc.12541.", "ArticleIdList": ["10.1111/jfbc.12541"]}, {"Citation": "Walker D., Lue L.F. Anti-inflammatory and immune therapy for Alzheimer\u2019s disease: Current status and future directions. Curr. Neuropharmacol. 2007;5:232\u2013243. doi: 10.2174/157015907782793667.", "ArticleIdList": ["10.2174/157015907782793667", "PMC2644496", "19305740"]}, {"Citation": "Anekonda T.S., Reddy P.H. Can herbs provide a new generation of drugs for treating Alzheimer\u2019s disease? Brain Res. Brain Res. Rev. 2005;50:361\u2013376. doi: 10.1016/j.brainresrev.2005.09.001.", "ArticleIdList": ["10.1016/j.brainresrev.2005.09.001", "16263176"]}, {"Citation": "Semwal P., Painuli S., Abu-Izneid T., Rauf A., Sharma A., Da\u015ftan S.D., Kumar M., Alshehri M.M., Taheri Y., Das R., et al. Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives. Oxidative Med. Cell. Longev. 2022;2022:1035441. doi: 10.1155/2022/1035441.", "ArticleIdList": ["10.1155/2022/1035441", "PMC9168095", "35677108"]}, {"Citation": "Sharifi-Rad J., Quispe C., Turgumbayeva A., Mertdin\u00e7 Z., T\u00fct\u00fcnc\u00fc S., Aydar E.F., \u00d6z\u00e7elik B., Anna S.-W., Mariola S., Kozir\u00f3g A., et al. Santalum Genus: Phytochemical constituents, biological activities and health promoting-effects. Z. F\u00fcr Nat. C. 2022. Online ahead of print .", "ArticleIdList": ["10.1515/znc-2022-0076", "36069757"]}, {"Citation": "Sharifi-Rad J., Herrera-Bravo J., Semwal P., Painuli S., Badoni H., Ezzat S.M., Farid M.M., Merghany R.M., Aborehab N.M., Salem M.A., et al. Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles. Oxidative Med. Cell. Longev. 2022;2022:5628601. doi: 10.1155/2022/5628601.", "ArticleIdList": ["10.1155/2022/5628601", "PMC9467740", "36105486"]}, {"Citation": "Javed Z., Khan K., Herrera-Bravo J., Naeem S., Iqbal M.J., Raza Q., Sadia H., Raza S., Bhinder M., Calina D., et al. Myricetin: Targeting signaling networks in cancer and its implication in chemotherapy. Cancer Cell Int. 2022;22:239. doi: 10.1186/s12935-022-02663-2.", "ArticleIdList": ["10.1186/s12935-022-02663-2", "PMC9336020", "35902860"]}, {"Citation": "Mangialasche F., Solomon A., Winblad B., Mecocci P., Kivipelto M. Alzheimer\u2019s disease: Clinical trials and drug development. Lancet Neurol. 2010;9:702\u2013716. doi: 10.1016/S1474-4422(10)70119-8.", "ArticleIdList": ["10.1016/S1474-4422(10)70119-8", "20610346"]}, {"Citation": "Ahmad I., Aqil F., Owais M. Modern Phytomedicine: Turning Medicinal Plants into Drugs. John Wiley & Sons; Hoboken, NJ, USA: 2006."}, {"Citation": "Bhattaram V.A., Graefe U., Kohlert C., Veit M., Derendorf H. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine. 2002;9((Suppl. 3)):1\u201333. doi: 10.1078/1433-187X-00210.", "ArticleIdList": ["10.1078/1433-187X-00210", "12222652"]}, {"Citation": "Salehi B., Sharifi-Rad J., Cappellini F., Reiner A., Zorzan D., Imran M., Sener B., Kilic M., El-Shazly M., Fahmy N.M., et al. The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action. Front. Pharmacol. 2020;11:20. doi: 10.3389/fphar.2020.01300.", "ArticleIdList": ["10.3389/fphar.2020.01300", "PMC7479177", "32982731"]}, {"Citation": "Leyva-Gomez G., Cortes H., Magana J.J., Leyva-Garcia N., Quintanar-Guerrero D., Floran B. Nanoparticle technology for treatment of Parkinson\u2019s disease: The role of surface phenomena in reaching the brain. Drug Discov. Today. 2015;20:824\u2013837. doi: 10.1016/j.drudis.2015.02.009.", "ArticleIdList": ["10.1016/j.drudis.2015.02.009", "25701281"]}, {"Citation": "Quispe C., Herrera-Bravo J., Khan K., Javed Z., Semwal P., Painuli S., Kamiloglu S., Martorell M., Calina D., Sharifi-Rad J. Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis. Prog. Biomater. 2022. Online ahead of print .", "ArticleIdList": ["10.1007/s40204-022-00198-3", "35904711"]}, {"Citation": "Sharifi-Rad J., Dey A., Koirala N., Shaheen S., El Omari N., Salehi B., Goloshvili T., Cirone Silva N.C., Bouyahya A., Vitalini S., et al. Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits. Front. Pharmacol. 2021;12:600139. doi: 10.3389/fphar.2021.600139.", "ArticleIdList": ["10.3389/fphar.2021.600139", "PMC8144503", "34045956"]}, {"Citation": "Docea A.O., Calina D., Buga A.M., Zlatian O., Paoliello M.M.B., Mogosanu G.D., Streba C.T., Popescu E.L., Stoica A.E., Birca A.C., et al. The Effect of Silver Nanoparticles on Antioxidant/Pro-Oxidant Balance in a Murine Model. Int. J. Mol. Sci. 2020;21:17. doi: 10.3390/ijms21041233.", "ArticleIdList": ["10.3390/ijms21041233", "PMC7072874", "32059471"]}, {"Citation": "Ramalho M.J., Andrade S., Loureiro J.A., do Carmo Pereira M. Nanotechnology to improve the Alzheimer\u2019s disease therapy with natural compounds. Drug Deliv. Transl. Res. 2020;10:380\u2013402. doi: 10.1007/s13346-019-00694-3.", "ArticleIdList": ["10.1007/s13346-019-00694-3", "31773421"]}, {"Citation": "Sharifi-Rad J., Quispe C., Butnariu M., Rotariu L.S., Sytar O., Sestito S., Rapposelli S., Akram M., Iqbal M., Krishna A., et al. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer Cell Int. 2021;21:318. doi: 10.1186/s12935-021-02025-4.", "ArticleIdList": ["10.1186/s12935-021-02025-4", "PMC8223345", "34167552"]}, {"Citation": "Islam M.S., Quispe C., Hossain R., Islam M.T., Al-Harrasi A., Al-Rawahi A., Martorell M., Mamurova A., Seilkhan A., Altybaeva N., et al. Neuropharmacological Effects of Quercetin: A Literature-Based Review. Front. Pharmacol. 2021;12:665031. doi: 10.3389/fphar.2021.665031.", "ArticleIdList": ["10.3389/fphar.2021.665031", "PMC8248808", "34220504"]}, {"Citation": "Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv. Drug Deliv. Rev. 2014;71:2\u201314. doi: 10.1016/j.addr.2013.08.008.", "ArticleIdList": ["10.1016/j.addr.2013.08.008", "23981489"]}, {"Citation": "Del Prado-Audelo M.L., Caballero-Floran I.H., Meza-Toledo J.A., Mendoza-Munoz N., Gonzalez-Torres M., Floran B., Cortes H., Leyva-Gomez G. Formulations of Curcumin Nanoparticles for Brain Diseases. Biomolecules. 2019;9:56. doi: 10.3390/biom9020056.", "ArticleIdList": ["10.3390/biom9020056", "PMC6406762", "30743984"]}, {"Citation": "Quispe C., Herrera-Bravo J., Javed Z., Khan K., Raza S., Gulsunoglu-Konuskan Z., Da\u015ftan S.D., Sytar O., Martorell M., Sharifi-Rad J., et al. Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective. Biomed. Res. Int. 2022;2022:1375892. doi: 10.1155/2022/1375892.", "ArticleIdList": ["10.1155/2022/1375892", "PMC8828342", "35155670"]}, {"Citation": "Naqvi S., Panghal A., Flora S.J.S. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Front. Neurosci. 2020;14:494. doi: 10.3389/fnins.2020.00494.", "ArticleIdList": ["10.3389/fnins.2020.00494", "PMC7297271", "32581676"]}, {"Citation": "Kamatou G.P.P., Viljoen A.M. A Review of the Application and Pharmacological Properties of \u03b1-Bisabolol and \u03b1-Bisabolol-Rich Oils. J. Am. Oil Chem. Soc. 2009;87:1\u20137. doi: 10.1007/s11746-009-1483-3.", "ArticleIdList": ["10.1007/s11746-009-1483-3"]}, {"Citation": "Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807\u2013818. doi: 10.1021/mp700113r.", "ArticleIdList": ["10.1021/mp700113r", "17999464"]}, {"Citation": "Islam M.T., Ali E.S., Uddin S.J., Shaw S., Islam M.A., Ahmed M.I., Chandra Shill M., Karmakar U.K., Yarla N.S., Khan I.N., et al. Phytol: A review of biomedical activities. Food Chem Toxicol. 2018;121:82\u201394. doi: 10.1016/j.fct.2018.08.032.", "ArticleIdList": ["10.1016/j.fct.2018.08.032", "30130593"]}, {"Citation": "Mohar D.S., Malik S. The Sirtuin System: The Holy Grail of Resveratrol? J. Clin. Exp. Cardiol. 2012;3:216. doi: 10.4172/2155-9880.1000216.", "ArticleIdList": ["10.4172/2155-9880.1000216", "PMC3613783", "23560248"]}, {"Citation": "Walle T. Bioavailability of resveratrol. Ann. N. Y. Acad. Sci. 2011;1215:9\u201315. doi: 10.1111/j.1749-6632.2010.05842.x.", "ArticleIdList": ["10.1111/j.1749-6632.2010.05842.x", "21261636"]}, {"Citation": "Sharifi-Rad J., Bahukhandi A., Dhyani P., Sati P., Capanoglu E., Docea A.O., Al-Harrasi A., Dey A., Calina D. Therapeutic Potential of Neoechinulins and Their Derivatives: An Overview of the Molecular Mechanisms Behind Pharmacological Activities. Front. Nutr. 2021;8:664197. doi: 10.3389/fnut.2021.664197.", "ArticleIdList": ["10.3389/fnut.2021.664197", "PMC8322439", "34336908"]}, {"Citation": "Sharifi-Rad J., Quispe C., Imran M., Rauf A., Nadeem M., Gondal T.A., Ahmad B., Atif M., Mubarak M.S., Sytar O., et al. Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits. Oxidative Med. Cell. Longev. 2021;2021:3268136. doi: 10.1155/2021/3268136.", "ArticleIdList": ["10.1155/2021/3268136", "PMC8315847", "34336089"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "12"}, {"Year": "2022", "Month": "9", "Day": "9"}, {"Year": "2022", "Month": "9", "Day": "11"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "29"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["36143299", "PMC9500804", "10.3390/jpm12091515", "jpm12091515"]}}], "PubmedBookArticle": []}